Top News Today | Firms abandon Alzheimer's drug | Showbiz

Home
US
- Chicago
- Denver
- Los Angeles
- New York
- San Francisco
- Washington
Sport
- Baseball
- Basketball
- Boxing
- Football
- Golf
- Hockey
- MLB
- Motorsport
- NBA
- NFL
- NHL
- Soccer
- Tennis
Business
Technology
- Gadgetlab
- Green
- Internet
- Mobiles and Wireless
- PC Games
- Science
- Scitech
- Space
Lifestyle
- Art
- Beauty
- Books
- Culture
- Dining
- Fashion
- Health
- Style
- Travel
Entertainment
- Celebrity
- Games
- Gossip
- Movies
- Music
- Showbiz
- Tv
- Tvshowbiz
World
- Africa
- Asia-Pacific
- Canada
- China
- Europe
- India
- Japan
- Latin America
- Middle East
- Russia
- UK
Politics

Firms abandon Alzheimer's drug

dailyexpress.co.uk (9 months and 11 days ago)

Aug 7, 2012

Pfizer and Johnson & Johnson are ending development of an intravenous formulation of a drug to treat Alzheimer's disease after the treatment failed in two late-stage clinical trials. full story

More news

A new drug may improve memory problems in people with Alzheimer’s disease (Video)

Alzheimer's Association writes that "Alzheimer's is a type of dementia that causes problems with memory, thinking and behavior." The symptoms with Alzheimer's usually develop slowly and get worse over time, becoming severe...

examiner.com (2 months and 7 days ago)

Promising Alzheimer's drug Gammagard fails key study

Experimental drug failed to slow mental decline or preserve physical function in major trial of 390 patients with Alzheimer's

cbsnews.com (11 days ago)

Bexarotene as Alzheimer's treatment begins Phase 1 clinical trials

The Alzheimer's Drug Discovery Foundation (ADDF) and BrightFocus Foundation today announced a funding collaboration that will support a Phase I human clinical trial to evaluate the cancer drug bexarotene as a treatment for Alzheimer's...

examiner.com (23 days ago)

Alzhiemer drug Gammagard fails to slow Alzheimer’s disease in late stage trial

Baxter International Inc., a drug manufacturer, said Tuesday it will stop developing a drug for treating mild to moderate Alzheimer's disease after a late-stage study showed it failed to reduce the decline of cognitive functions and preserve...

examiner.com (11 days ago)

Participants sought in Alzheimer's drug trial

PLAINS TWP. 8212 Area residents can receive free memory screenings on Tuesday that could, in turn, help determine if they are eligible to participate in a clinical trial of a drug designed to prevent Alzheimer's disease.

timesleader.com (30 days ago)

Alzheimer's drug to get trial

Patsy Quinn knows what the agitation that so often accompanies Alzheimer’s disease can mean.

lvrj.com (1 month and 9 days ago)

Alzheimer's treatment one step closer to human trials at Case Western Reserve University

Last year, researchers at CWRU discovered that a cancer drug worked amazing well at treating Alzheimer's disease in mice. Now, they're one step closer to testing the drug in people.

cleveland.com (23 days ago)

Alzheimer's drug to get trial; Las Vegas volunteers sought

Patsy Quinn knows what the agitation that so often accompanies Alzheimer’s disease can mean.

lvrj.com (1 month and 9 days ago)

Lundbeck to develop, sell Alzheimer's drug with Otsuka

COPENHAGEN (Reuters) - Danish pharmaceutical group Lundbeck said on Tuesday it had agreed to work with Japan's Otsuka to develop and commercialize an Alzheimer's drug.

reuters.com (1 month and 22 days ago)

Baxter's Alzheimer's disease drug fails in late-stage trial

(Reuters) - Baxter International Inc said a late-stage study of its experimental drug to treat Alzheimer's disease failed to reduce the decline of cognitive functions and preserve functional abilities.

reuters.com (11 days ago)

Firms abandon Alzheimer's drug

Advertisement

Most read

Most popular

Follow us

Search